NAV · Direct-Growth
As of 1 Oct 2026 · AMFI
Returns
Beats category
1Y, 3Y, 5Y all ahead
Cost
High
1.00% vs 0.83% peers
Volatility
Below average
14.8% vs 16.1% cat (3Y)
Consistency
Steady
positive in 9 of 12 years
Beats its Sectoral / Thematic category on 1Y, 3Y & 5Y — and has been steadier than peers.
1Y return
+12.0%
+9.2 vs cat
3Y CAGR
+18.2%
+4.2 vs cat
5Y CAGR
+13.1%
+1.0 vs cat
AUM
₹9.5K Cr
fund size
Expense
1.00%
direct plan
Volatility 3Y
14.8%
▼ vs 16.1%
Go deeper on Nippon INDIA Pharma FUND
Two data-only views, computed from this fund's real NAV history — no projections.
In plain English
NIPPON INDIA PHARMA FUND is a Sectoral / Thematic scheme from Nippon India. The portfolio is ~98% in equities. Long-run track record: about 13.1% CAGR over 5 years. Volatility is typical for equity — 20–30 % drawdowns happen during market stress. Worst historical drawdown: -24% in May 2017, recovered in 15 months. Wrong fit if you need this money in less than 7 years.
Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.
NAV history
Showing Direct · Growth · INF204K01I27
NAV (Direct-Growth)
₹628.4076
Last 1Y
+12.36%
Drawdown stories
The crashes you should know about — and how long the fund took to recover.
May 2017
-24.0%Peak ₹160.57 on 30 Oct 2015 → trough ₹122.00 on 29 May 2017 (19 months down).
Mar 2020
-21.2%Peak ₹175.55 on 19 Feb 2020 → trough ₹138.36 on 23 Mar 2020 (1 months down).
Jun 2022
-19.5%Peak ₹341.49 on 15 Sept 2021 → trough ₹274.97 on 17 Jun 2022 (9 months down).
Oct 2019
-17.4%Peak ₹173.80 on 7 Sept 2018 → trough ₹143.56 on 7 Oct 2019 (13 months down).
Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.
Honesty score
A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.
Honesty score
4 / 5
Solid scheme on the dimensions we check. No red flags.
Expense ratio
1.00% — typical for category.
AUM size
₹9.5K Cr.
Sector concentration
Top 3 sectors = 98.0% — heavy concentration risk.
Performance
Returns for various periods, with category average and peer rank.
Portfolio composition
Asset allocation
- Equity98.00%
- Cash2.00%
By market cap
- Large cap30.61%
- Mid cap38.82%
- Small cap30.05%
- Others0.52%
Concentration
Holdings
40
Avg market cap
₹68.9K Cr
Top 10 stocks
56.78%
Top 5 stocks
37.03%
Top 3 sectors
98.00%
Top holdings
Top 15 positions by weight, latest disclosure.
Fundamentals (vs category)
Portfolio-weighted ratios, compared with the category average.
Risk metrics
Standard deviation, Sharpe, Sortino, Beta — all vs category average.
Peers in Sectoral / Thematic
Other schemes in the same SEBI category, ranked by AUM.
Available plans & options
Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.
NEW
See your SIP through Indian market history
Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.
Try Wealth Time MachineAI · Free
Find what's really inside your funds
Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 key insights, written by AI in plain English.
Run Portfolio X-Ray